each of the states for which it has been granted. European patents, once conferred, basically become a bundle of national rights, where disputes have to be solved by national courts of the contracting states (COM (2011) 287 final). The patent opposition procedure of the European patent is therefore the only exception to the rule that, after the grant of a patent, the right becomes a bundle of national rights; the opposition procedure (reviewed by the Boards of Appeal of EPO) is a centralized procedure for the evaluation of validity of a European patent directly after grant, thus affecting the patent right in all EU Member
States (Aerts 2014: 88-89) . National patents, whether or not granted by EPO, continue to be subject to the Brussels I Regulation regarding rules assigning jurisdiction (Cook: 2012, 569) . This means that under the EPC patents, either national or regional (EU), are enforced at national level, on per-country basis. Furthermore, the European Court of Justice held that European patents are national rights that must be enforced nationally, that it was unavoidable that infringements of the same European patent have to be litigated in each relevant national court, even if the lawsuit is against the same group of companies, and that cross-border injunctions are not available (C-4/03 Antriebstechnik v Lamellen; C-539/03 Roche v Primus).
The national treatment principle is also present in article 3 of the TRIPS Agreement as well as the Paris Convention. The applicability of national law also derives from article 8 of Regulation (EC) 864/2007 regarding the laws applicable to non-contractual obligations in the context of intellectual property rights. When viewed from the practice standpoint, it could be stated that, despite the existence of international agreements, the states still have certain discretion in applying national patent law in local patent offices when going through with actual patent applications in every day practice. Such national competence is especially evident for national patent applications when each country continues to conduct separate patent examinations (Webster et al. 2012: 6) .
The whole picture may change when the Unified Patent package enters into force, as alongside the Unified Patent national as well as regional European patents will continue to exist. Therefore, in order to seek for protection in the EU, the applicant will have options to either apply separately for the national patent in every Member State of interest, or as a second option, for the European (regional) patent, and then have it validated as is the currently existing option, or as a third option, have the patent validated as an Unified Patent, or as the last option to apply for the Unified Patent and have it later validated in EU Member States that are not part of the Unified Patent package. Still, even in case of applying for the European Unified Patent, it will not be granted if the set of patent claims differ between the Member States where they were applied for and the Unified Patent it would create significant risks considering that Unified Patent system works on the all-ornothing principle.
Also, as the national patent claims and regional European patents will remain to exist alongside the Unified Patent system, there is a concern that it will affect dispute settlement and jurisdiction issues because the Unified Patent Court will not have any jurisdiction over national patent disputes, or over disputes involving non-Members of the Unified Patent package. Therefore, in extreme situations, when the infringement claim for example involves identical patent claims granted on national level, regional level as well as under the Unified system in three different countries, then it could very well mean that the jurisdiction will fall within the competences of the CJEU, the Unified Patent Court as well as the national court.
Enhanced cooperation in the area of unified patent protection is aimed at fostering scientific and technological advance and the functioning of the internal market. In other words, it furthers the objectives of the Union, protects its interests and reinforces its integration process in accordance with article 20(1) of the TEU(C-274/11 Kingdom of Spain v Commission). In the context of this unified patent scheme, the EPO has been entrusted with the task of granting unified patents, if the system eventually takes effect. It is also foreseen that the EPO will be in charge of centrally administering the unitary patent, levying the annual renewal fees and distributing them to the participating EU Member
States. The role of EPO will still remain in question considering that in the current state of affairs it is not linked to the EU.
The implications of jurisdictions and developments in EU patent regulations
Substantive patent law relates mainly to acts of direct or indirect infringement. In this regard, simple judicial cooperation and discussions alone cannot avoid contradictory interpretations of European patent law as there is a lack of uniform rules of interpretation 8 throughout Europe (Luginbuehl 2011: 137) . As already mentioned, according to the EPC art 2 (2) and article 64 (1) the grant of European patents falls in the competence of national laws. Following this logic, all cases of patent infringements, should also be dealt by national laws that established the legal basis for granting a patent in a specific territory in the first place. Therefore, substantive patent law should, by deduction from the same logic, also be interpreted according to national laws. Article 16(4) of the Brussels I Regulation provides for exclusive jurisdiction of national courts in proceedings concerned with the registration or validity of patents (van Engelen 2010).
As for European patent claims, according to articles 1 and 2 of the Protocol on Jurisdiction and the Recognition of Decisions in respect of the Right to the Grant of a European Patent, the courts of the Contracting States shall, in accordance with Articles 2 to 6, have jurisdiction to decide claims, against the applicant, to the right to the grant of a European patent in respect of one or more of the Contracting States designated in the European patent application. From the logic of article 16(4) of the Brussels I Convention, one could therefore deduct that the exclusivity of national competence extends not only to infringement cases, but also to the claims regarding challenges to patent registration and validity. Just as a remark, needless to say, the grounds for challenging validity and infringement claims have different grounds.
In GAT v LuK, the CJEU held that Article 16(4) of the Brussels Convention is to be interpreted as providing exclusive jurisdiction to the courts of the territory of registration in all matters concerning the validity of a patent, irrespective of how such issue is raised. Any proceedings which relate to the validity of the patent may only be heard by the courts in the territory in which the patent is granted (C-4/03 Antriebstechnik v Lamellen). In addition the exclusive national jurisdiction provided for by that provision should apply whatever the form of proceedings in which the issue of a patent's validity is raised.
Considering that for challenging the validity of European patents in pre-and post-grant proceedings under the provisions of EPC, there is no principle of binding case law (EPO T-1099/06, Max-Planck-Gesellschaft v BASF) then it means that the binding effect of the EPO´s Boards of Appeal decisions is extremely limited.
A patent held to be valid by the EPO in respect of some or all of the claimed subject matter can still be attacked at the national level. Furthermore, the national challenges of patent validity can be brought before the national court despite the limitation of the 9 9 month time period foreseen for challenging validity claims for European patents granted by EPO, meaning that the national litigation on validity can, in principle, take place in parallel to the EPO claims. It is important to point out though that as a general principle, the EPO´s decisions should enjoy primacy before national patent decisions while national decisions regarding patentability should have no effect on future application procedures at EPO. Both applications either under PCT or EPC can be made directly without applying for a national patent first, and in regards of a European patent then in the case of invalidation in one of the Member States, it still remains valid in others.
The validity claim of a patented subject matter made in national jurisdictions should be contested in the place of patent registration. While the EPO centralized procedure is without any doubt the cheapest and fastest way to challenge patent grant (around half the price compared to litigation in each EPC contracting state separately), as opposed to challenging the validity at the national level, it has a time limit (Thomas et al. 2014) . At the same time, both the litigation and the EPO procedures for challenging the validity are time consuming, usually taking around 5 years before the final decision is reached. In the context of patent rights, it certainly has a crucial significance as the economic situation is in constant flux.
In this context, it is interesting to point out the characteristic of European patent law meaning that national patents may actually co-exist alongside European patents, thereby simultaneously falling under the same jurisdiction. For example it may occur in a situation mentioned in article 139(3) of the EPC: Any Contracting State may prescribe whether and on what terms an invention disclosed in both a European patent application or patent and a national application or patent having the same date of filing or, where priority is claimed, the same date of priority, may be protected simultaneously by both applications or patents.
In an era in which intellectual property rights are still for the most part national rightsand a proprietor mostly owns a bundle of national intellectual property rights instead of one supranational IP rights-having to deal with an infringement in multiple jurisdictions still means litigation might be needed in a great number of countries to enforce intellectual property rights within the European Union (Cook 2012: 596) .The comprehensive and exclusively applicable set of rules of the Brussels Convention should be applied by the national courts in an uniform way and, in order to ensure uniformity of the judgments, the As already mentioned, cases related to infringements of patent rights also fall in the competence of national courts. Under Article 64(3) of EPC, any infringement of a European patent shall be dealt with by national law, with the EPO having no legal competence to deal with, and to decide on patent infringements, in the Contracting States to the EPC. It means that patent infringement of both national and European Patents are dealt with by national courts. There is currently no avenue of appeal from the EPO to the CJEU directly.
In the same way as for the cases dealing with patent infringement in the context of multiple locations, the EU patent cannot be disputed in a centralized manner but every infringement case (although potentially being identical) has to be sued in every single territory separately and therefore is dealt with national jurisdiction. From the patent owner´s perspective, such multiple claims are not only costly but also time consuming, and also different procedural rules are applied meaning that the same case might end up with contradictory judgments in every national jurisdiction. The Court has held that for Article 6(1) of the Brussels Convention to apply there must exist, between the various actions brought by the same plaintiff against different defendants, a connection of such a kind that it is expedient to determine the actions together in order to avoid the risk of irreconcilable judgments resulting from separate proceedings (C-616/10 Solvay v Honeywell).
However, in order to determine whether there is a likelihood of contradiction, it is not sufficient that there might be a divergence in the outcome of the dispute, because the divergence must also arise in the context of the same situation of law and fact. Therefore, there must be a close connection between the claims, and even if it is targeted against the same defendants in all states or in case of different defendants, still dealing with the same type of infringement, it is not enough to tie the cases together.
As a general rule applicable to patent infringement claims, according to the Brussels Convention article 2, the case should fall in the competence of the court where the defendant is domiciled. As patent litigation is usually linked to legal entities then it may create not only confusion but also a chance for forum-shopping, as for legal entities the place of domicile can be defined very differently among Member States. The whole picture becomes foggier when dealing with a litigation involving a branch of the main business or in case of multiple co-defendants. For example, under current circumstances it could very well happen that an American company holding a European patent that is validated in Germany, England and the Netherlands may sue the infringer domiciled in France, for a patent infringement occurred in Germany, in the Netherlands national court. It gets even more confusing in cases related to tort or delict as according to article 5 of the Brussels Convention the case should be reviewed in the jurisdiction where the harmful event occurred. The problem is that this concept can be interpreted in either being a place where the harmful event actually occurred or the place that gave rise to the harmful event.
Also, from the patentee´s perspective, other determinants that could affect the final outcome of the case should be taken into account when calculating where to bring the action to court, such as the availability of interim junction measures in the national jurisdiction or even proving one´s case and providing evidence that is also practiced differently among Member States. Moreover, there are aspects to take into consideration in respect of the diverging quality of national courts (as there are usually no patent or intellectual property specific courts, then the judge is expected to not only have legal knowledge but also expertise in the area of chemistry, engineering etc. to be able to understand the real substance of the case) and in different practices which could lead to diverging court decisions.
As for the future of litigation procedures, Community competence will probably gradually replace current practices after the ratification of the Community Patent package as patent litigation concerning validity and infringement will be handed to the Unified Patent Court having the competence only over the contracting states (excluding for example Spain). The Unified Patent Court will also have competence over currently Forum shopping in patent matters is exercised also in national level as the quality and the experience of courts varies greatly (Luginbuehl 2011: 42).
In conclusion, considering that with the unified patent package national as well as regional European patents will still remain in co-existence with the unified patent, further confusion might be created on determining jurisdiction and the place of litigation. This is especially important when considering that the EPO decisions will become appealable to the Unified Patent Court (the first instance of the UPC may and the court of appeal must address the prejudicial questions regarding the applicability of EU law to the European Court of Justice), while the latter will still have no jurisdiction over national patent disputes or disputes involving Member States that are not part of the unified system.
The effects of EU competence on the TRIPS patent provisions
After the entry into force of the Lisbon Treaty, in terms of the EU's exclusive common commercial policy, competence now covers commercial aspects of intellectual property rights and is likely to be broader than the EU's internal exclusive competence to legislate IP. Although the TRIPS Agreement was signed as a mixed agreement, the rulings of CJEU 13 account that the EU possesses legal personality doubts might be raised in regards of the extent of its actual competence, bearing in mind that such an entity could be either limited according to their limitations of competences, or whether it is indeed unlimited and independent of the limited competences of an organization.
If it was limited, it would mean that the EU would only be bound to those parts of the WTO agreement for which it had competence (Steinberger 2006: 841) . Considering the breadth of art 216 of the TFEU one could say that the EU has unlimited legal personality and therefore could potentially bind itself to all provisions of the WTO agreement. This would mean that Member States are not only absent for the negotiating aspect, as intellectual property law falls in the sole external competence of the Union, but it also can be said that the final effects of TRIPS are determined by the EU, and through the final interpretation of the CJEU. Although article 3 (1) of the TFEU states that the areas of exclusive competence only refer (among other areas) to aspects of common commercial policy , in the light of art 207 TFEU that declares intellectual property law as belonging to the commercial sphere of the Union, the competence obviously embraces a much wider spectrum than it initially appears.
In one of the first documents dealing with the issue, Opinion 1/94 of the Court of Justice, the Commission recognized that there is a connection between intellectual property law and the trade of goods, as the objective of TRIPS is to harmonize the protection of intellectual property on a worldwide scale. At the same time, the Commission of the day did not recognize the exclusive external competence of the EU as regards TRIPS. The Commission stated that the EU shared joint competence to conclude TRIPS (Opinion 1/94) and that the exclusive competence of the EU was limited to certain areas of intellectual property law and it did not necessarily extend to commercial aspects of the latter. It was stated in the Opinion that intellectual property rights do not relate specifically to international trade; they affect internal trade just as much as, if not more than, international trade. Also, the Commission pointed out the fact that there were many areas of intellectual property law covered by TRIPS that had not been harmonized in the Union level by that time. As for patent law, there are currently two directives legislated on the This scenario has recently changed with the entry into force of the Lisbon Treaty, as intellectual property rights are considered to fall fully within the context of the international commercial policy of the Union.
On the one hand this certainly strengthens the EU's position not only from the legal aspect, but from the political aspect as well considering that in this way the EU could maintain its image as a global market player, while at the same time clearing any uncertainty as regards to defining competence; especially useful when negotiating international agreements as there is no need for defining the line between the competence of the Union and of its Member States. The TRIPS Agreement states that the term intellectual property refers to all categories of intellectual property, therefore it should embrace everything from copyright to undisclosed data and the protection of integrated circuits.
On the other hand the preamble of the TRIPS Agreement clearly states that it is primarily targeted at the liberation of international trade and to strengthen the protection of intellectual property right on a worldwide scale (TRIPS Agreement preamble).
Considering that the substantive contents of TRIPS is not particularly trade related, one could say that there is some room for debate as to what might exactly be considered under the notion of the EU's common commercial policy in the context of trade agreements relating to commercial aspects of intellectual property rights. It seems that in the case where an act is targeted to promote, facilitate or govern international trade, it should fall within the notion of common commercial policy, but whether the idea was to create a link of extension between TRIPS and TFEU art 207, meaning that the commercial aspects of intellectual property rights are meant as the ones encompassing in TRIPS, is not certain. Therefore one could say that, at the time, patent law for example could not fall in the sole competence of the Union due to the lack of harmonized legislation. However, with the entry into force of the Lisbon Treaty, and especially in the light of the Daiichi Sankyo case, substantive patent law, irrespective of whether legislated or not, would now fall within the sole competence of the Union as falling in the category of foreign trade, or more precisely, using the broader notion of the TFEU, to the commercial sphere of the latter. Therefore, what may be deduced is that the Union´s competence is in fact broader than that simply envisioned in the TRIPS, which only deals with the trade related aspects of intellectual property rights, which are obviously a narrower notion compared to the one in the TFEU (commercial aspects). Of course, it raises another concern as to whether any possible future agreements containing intellectual property provisions would also fall within the competence of the Union, as while the competence over the TRIPS can be justified by its trade related nature, it is questionable whether the Union will have sole competence for any other type of intellectual property related agreement even after the Daiichi Sankyo case, as the notion of commercial aspects of intellectual property rights are not so far clearly defined.
It is still a matter for debate as to whether after the Daiichi Sankyo case there is a need to further worry about drawing a distinguishing line between on the one hand the commercial aspects of intellectual property law, and on the other non-commerce related intellectual property law, when simply interpreting substantive patent law for example.
However it certainly makes a difference when negotiating Free Trade Agreements with third countries which obviously would still be covered by the exclusive competence, although in the context of TRIPS, it would not extend to TRIPS plus provisions I that fall outside the TRIPS Agreement but at the same time are widely enforced during negotiations for Free Trade Agreements. The other side of the coin is the fact that while acknowledging its wide competence in the area of intellectual property law, the Union also takes on responsibility for its role as an international body.
Interpretation of substantive patent law in the light of the Daiichi Sankyo case
The In the Nakajima case, a litigant argued that the European Council´s anti-dumping regulation did not comply with the anti-dumping measures of the GATT; in its decision, the CJEU found that this regulation was adopted to comply with the EU's WTO obligations, and as a result, the regulation could be examined for legality with regard to WTO obligations. The Fediol case dealt with the existence of a regulation that permitted producers to complain to the Commission about illicit commercial practices of third-party countries (C-70/87 Fediol v Commission of the European Communities). The Court found that, although the GATT had no direct effect, the flexibility that characterizes the provisions of GATT in several areas did not prevent the Court from interpreting and applying the rules of GATT regarding a given case, in order to establish whether certain specific commercial practices should be considered incompatible with those rules. Also, since the economic agents concerned are entitled to rely on the GATT provisions as a basis for their complaint, they had the right to request that the Court review the legality of the Commission's decision in applying those provisions.
Conversely, in the FIAMM case (C-120/06 and C-121/06 FIAMM and Fedon v
Council), that dealt with non-contractual liability of EU institutions in the event of breach of WTO obligations, the CJEU found that plaintiffs could not rely on WTO law when arguing for invalidity or for damages; WTO agreements are not in principle among the rules in the light of which the Community courts review the legality of action by the Community institutions. Consequently, the court affirmed that there is no possible way, absent Nakajima and Fediol, for private litigants to invoke WTO law before a court to obtain damages or invalidate EU law.
Therefore, the Nakajima and Fediol cases are the two exceptional scenarios that would create the possibility to rely on WTO/GATT law in order to review the lawfulness of EU acts.
The issue regarding the interpretation of the TRIPS provisions has gained particular attention considering that the agreement was concluded by the EU as well as its Member
States as a mixed agreement that has the same legal status in the Union legal order as purely the Advocate General's observations, the CJEU held that article 27 falls within the exclusive competence of the EU, including the common commercial policy and particularly commercial aspects of intellectual property. The Court also noted that its opinions prior to treaty modifications were no longer applicable. The CJEU further stated that, based on those conclusions, there was no further need to consider whether national courts may accord direct effect to Article 27, as the first question regarding competence was determined, in that competence belonged to the EU. This is a major decision in respect of international intellectual property law within the EU because all the TRIPS provisions may fall within the exclusive competence of the EU.
Firstly, a few words about the Daiichi Sankyo case, which evolved around two aspects.
The first was the question of whether the substantive provisions regarding art. 27, (patentable subject matter), of the TRIPS Agreement, falls within the competence of the EU or whether the Member States continue to have a primary competence, and if so then can Member States accord direct effect to that provision. The second question was more specific to intellectual property law, as there was a doubt whether in the case the additional certificate of protection, or even the ground patent, applied solely to the manufacturing process of an active ingredient or would also embrace the active ingredient itself. As for the latter question the court said that the process patent does not extend to the active ingredient but solely to the process. Taking these aspects into account, it is interesting to note that this exclusive competence over substantive patent law is not affected by the fact that the EU has not yet legislated in the specific field, apart from limited sectorial interventions (Directive 98/44/EC). As discussed in respect of the Dior or Merck cases, the key factor in determining EU competence at the time was whether the Union had exercised EU wide legislation in the field or not. Apparently, this aspect is no longer relevant. Therefore, the lack of common rules on substantive patent law no longer seems to be an impediment for the determination of EU competence. TFEU. The EU has thus competence, among other situations, when it is necessary to conclude an agreement or take internal action in order to achieve, within the framework of its policies, one of the objectives referred in the treaties (Mylly 2014: 7).
At the same time TRIPS continues to an extent in having a direct effect in the Union. for European patents as they also become national patents after the validation procedure.
Therefore, even if the EU has no competence to interfere with the decisions of EPO in the framework of EPC, it can interfere in a later stage when European patents become national patents after the validation at local patent offices; and this competence does not only affect patent infringement cases but also patent validation claims. At the same time,
considering that the TRIPS Agreement only establishes minimum standards for setting patentability criteria, then from the substantive patent law perspective, it should not create any significant change (it will most probably affect the issues related to patentability of 
Conclusion
In conclusion, it can be said that there is some change ahead for European patent law not only in the light of the Daiichi Sankyo case that has changed the interpretation of substantive patent law deriving from the TRIPS Agreement, but also in the light of the new unified patent package that may soon take effect. It is difficult to predict the final outcome, but what is certain so far is that with the unified patent package national, as well as current regional European patents, will continue to co-exist. And, with the addition of international applications, as well as the possibility of filing unified applications, confusion might be created. Also, the Unified Patent Court will have no jurisdiction over national patent disputes or disputes involving Member states that are not part of the unified patent package (Spain for example). At the same time it will have jurisdiction over not only the unified patents but also the currently existing regional European patents, at least during the transition period of seven years. In contrast to the current state of affairs, the EPO´s decisions will become appealable to the Unified Patent Court, and there will be the possibility to make references to CJEU for preliminary ruling. Considering that the unified patent package does not cover all EU member states (for example Italy only takes part of the unified patent court but not the unified patent package itself), it could lead to further confusion. Also, the role of EPO will need to be clarified as currently it is in no way connected to any EU institutions, but it seems that in the future it is expected to move closer to the latter considering that EPO will be in charge of administering unified patents.
As for the substantive patent provisions of TRIPS, and the possibility for applying direct effect, it seems that it still continues to be exempt as substantive patent provisions fall in the competence of the EU and form an integral part of its commercial policy. (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) .
